IBER
Ibere Pharmaceuticals
IBER
IBER
Delisted
IBER was delisted on the 1st of March, 2023.
47 hedge funds and large institutions have $99.8M invested in Ibere Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
47
Holding in Top 10
–
Calls
$114K
Puts
–
Top Buyers
| 1 | +$11.7M | |
| 2 | +$3.27M | |
| 3 | +$2.42M | |
| 4 |
D.E. Shaw & Co
New York
|
+$2.36M |
| 5 |
GCL
Glazer Capital LLC
New York
|
+$1.71M |
Top Sellers
| 1 | -$745K | |
| 2 | -$432K | |
| 3 | -$35.3K | |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$29K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$49 |